Navigation Links
Columbia engineers patch a heart
Date:5/6/2011

Researchers at Columbia Engineering have established a new method to patch a damaged heart using a tissue-engineering platform that enables heart tissue to repair itself. This breakthrough, recently published in the Proceedings of the National Academy of Sciences http://www.pnas.org/content/early/2011/04/19/1104619108.long, is an important step forward in combating cardiovascular disease, one of the most serious health problems of our day.

Led by Gordana Vunjak-Novakovic, Professor of Biomedical Engineering at Columbia University's Fu Foundation School of Engineering and Applied Science, the researchers developed a novel cell therapy to treat myocardial infarction (heart damage that follows a heart attack). They were able, for the first time, to combine the use of human repair cells that were conditioned during in-vitro culture to maximize their ability to revascularize and improve blood flow to the infarcted tissue with a fully biological composite scaffold designed to deliver these cells to the damaged heart. With this platform, they could both keep the cells within the infarct bed (in contrast to the massive cell loss associated with infusion of cells alone) and enhance cell survival and function in the infarct bed, where most of the cells would have died because of the obstruction of their blood supply.

"We are very excited about this new technique," said Dr. Vunjak-Novakovic. "This platform is very adaptable and we believe it could be readily extended to the delivery of other types of human stem cells we are interested in to rebuild the heart muscle and further our research of the mechanisms underlying heart repair."

In effect, the Columbia Engineering team (with Amandine Godier-Fournemont and Timothy Martens as lead authors) removed the cells of a human heart musclethe myocardiumleaving a protein scaffold with intact architecture and mechanical pr
'/>"/>

Contact: Holly Evarts
holly@engineering.columbia.edu
212-854-3206
Columbia University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Columbia professor to discuss good, bad aspects of choice at NJIT March 23 talk
2. Columbia engineer observes surprising behavior of cells during blood-vessel formation
3. Columbia University uses technological innovation to study bone structure
4. Columbia University Medical Center announces 2010 Katz Prizes in cardiovascular research
5. Columbia engineer part of team to receive $6.2 million DOD grant for blast research
6. Columbia University Medical Center announces 2009 Katz Prizes in Cardiovascular Research
7. Columbia University scientist devises new way to more rapidly generate bone tissue
8. Salmon smolt survival similar in Columbia and Fraser rivers
9. Similar survival rates for Pacific salmon in Fraser, Columbia Rivers raises new questions
10. Columbia to award 2008 Horwitz Prize to Arthur Horwich & Ulrich Hartl for cellular protein folding
11. Chemical engineers at UCSB design molecular probe to study disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 16, 2014 Research and Markets ... the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend ... for medical sensors in biomedical applications. Chemical sensors ... and correct diagnosis during surgical procedures. The Global ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is ... Facial recognition system measures the overall facial feature ... mouth, and the distance between eyes. Facial recognition ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... to their offering. One major ... of multimodal biometric systems. Multimodal biometric systems utilize ... verification and identification purposes. This helps to reduce ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... New Rochelle, NY, April 3, 2009A novel technique ... challenge the market dominance of the current, widely ... News ( GEN ). Some scientists believe ... for gene-expression analysis, will eventually rival microarrays in ...
... the 82-ton-force, earthquake-simulation shake table could not knock down ... Nevada, Reno alumna and civil engineer Darcey Donovan. ... foundation and clay plaster walls, the way she builds ... acceleration/shaking than was recorded at the 1994 Northridge, Calif. ...
... allergy may be malfunction of the respiratory epithelium, which ... the epithelium. Two studies by Finnish research groups on ... biomedical journals (1) Allergy , and (2) ... Research on the mechanisms of allergy has focused on ...
Cached Biology News:Straw bale house survives violent shaking at earthquake lab 2Straw bale house survives violent shaking at earthquake lab 3Malfunction of the respiratory epithelium is a cause of allergy? 2
(Date:12/17/2014)... (PRWEB) December 17, 2014 Xeno ... Excellence following its most recent COLA inspection. Xeno ... COLA, a national healthcare accreditation organization. Accreditation is ... of quality in day-to-day operations, demonstrate continued accuracy ... a rigorous on-site laboratory survey. , ...
(Date:12/17/2014)... , Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... on gynecologic disease, today announced the next step in ... premier bio-analytics solutions provider with the naming of current ... and Chief Executive Officer, while current Chairman of the ... to serve as Chairman. These changes are effective January ...
(Date:12/17/2014)... SAN FRANCISCO, Calif. , Dec. 17, 2014 ... results of a Phase 2 study evaluating the ... the treatment of patients with severe, chronic itch ... current standard of care, including topical steroids and ... was percent change in Visual Analog Scale (VAS) ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel ... (NASDAQ: BCLI ), a leading developer of ... that wholly-owned subsidiary Brainstorm Cell Therapeutics Ltd. was awarded ... Israel,s Office of the Chief Scientist (OCS).  ... in receipt of grant support from the Office of ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
... trend toward miniaturization, carbon nanotubes which are about ... several unique and very useful properties have become ... nanosized electronic and mechanical devices. But it is precisely ... clump together, that make it difficult for scientists to ...
... and ... excellent value, BOSTON, May ... and medical image and information management solutions,today announced that it has ... use MEDITECH(TM) as their health,information system. AMICAS will be showcasing Vision ...
... industry to benefit ... recruitment efforts, MINNEAPOLIS, May 27 Leading ... strengthened the,pharmaceutical side of its business with the ... commitment to leveraging differentiators unique,to the medical device ...
Cached Biology Technology:Weizmann Institute scientists create new nanotube structures 2AMICAS Announces Integrations at More Than 100 MEDITECH Facilities 2AMICAS Announces Integrations at More Than 100 MEDITECH Facilities 3ThreeWire Expands Presence in the Pharmaceutical Arena 2